Medigus To Present Data on MUSE(TM) Combined with Peroral

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Medigus To Present Data on MUSE(TM) Combined with Peroral Treatment of Achalasia At United European Gastroenterology Week 2014

OMER, Israel, Oct. 20, 2014 (GLOBE NEWSWIRE) -- Medigus Ltd. (TASE: MDGS), a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, today announced that it will present findings from an animal feasibility study, Reflux Disease Treatment - MUSE TM   (formerly SRS TM ) Procedure Combined with POEM in the Treatment of Achalasia: A Feasibility Study in an Animal Model , during Poster Session # 1623 at the upcoming United European Gastroenterology Week (UEGW), being held in Vienna, Austria, from October 18 - 22, 2014.  Study findings were previously presented in April of this year.

"We're proud to be sharing our preliminary study results at such a prestigious forum as UEGW," stated Chris Rowland, CEO of Medigus. "The MUSE TM System is a revolutionary device that is leading the transition from invasive gastric surgical procedures to less invasive, patient-friendly techniques by allowing endoscopists to potentially treat GERD that results after certain achalasia treatment procedures with a simplified fundoplication procedure that is administered transorally.  A procedure leveraging our system can yield results similar to standard laparascopic treatment for GERD, but without needing incisions. We look forward to engaging key members of the GI community on the benefits of more broadly adopting The MUSE TM System."

Achalasia is a disorder of an unknown cause that results in degeneration of the esophageal muscles and the nerves that control them.  Common symptoms include difficulty swallowing, chest pains, and regurgitation of stomach contents.  Left untreated, complications from achalasia may lead to lung problems, weight loss and even cancer of the esophagus.  Patients can be diagnosed with X-ray, endoscopy, or esophageal manometry.  Treatment options include oral medications, dilation of the esophagus, invasive surgery, and injection of muscle-relaxing medicines (such as botulinum toxin) directly into the esophagus. There is no confirmed cure, however, and treatment results vary by patient.  Oftentimes, patients report having developed GERD following treatment for achalasia.

The MUSE TM system merges the latest technological advances in visualization, ultrasound and surgical stapling to enable safe, incisionless procedures within the GI tract. It performs transoral anterior fundoplications with standard surgical staples in a way that is less invasive than traditional, laparoscopic therapies.  Because of this, the device may enhance both patient care and hospital efficiency through lower costs and shorter stays.  The procedure can be performed by a single operator in an endoscopy suite.

UEGW attendees can visit the Medigus booth (#Y6) to learn more about the MUSE TM System.

The MUSE TM System Poster Presentation at UEGW
Poster Session # 1623
Wednesday, October 22, 2014 from 9:00 AM - 2:00 PM in the Poster area - Hall XL

Poster Presentation: UEG14ABS-1152
Reflux Disease Treatment - MUSE TM (formerly SRS TM ) Procedure Combined with POEM in the Treatment of Achalasia: A Feasibility Study in an Animal Model  Bozzi, Rosamaria; Roy-Shapira, Aviel; Schettino, Pietro; Cattaneo, Fabio; Pezzullo, Angelo M.; Cataneo, Domenico

Medigus will be exhibiting Hall Y, Booth # 6 for the duration of the conference. Exhibition dates and hours are:

Monday, October 20, 2014 9:00 - 17:00
Tuesday, October 21, 2014 9:00 - 17:00
Wednesday, October 22, 2014 9:00 - 14:00

About UEGW

UEG Week is the largest and most prestigious gastroenterology meeting in Europe and has developed into a global congress. It attracts over 14,000 participants each year, from more than 120 countries, and numbers are steadily rising. UEG Week provides a forum for basic and clinical scientists from across the globe to present their latest research in digestive and liver diseases, and also features a two-day postgraduate course that brings together top lecturers in their fields for a weekend of interactive learning.

From October 18-22, 2014, UEG will connect everyone to its annual meeting via livestream on www.ueg.eu . State-of-the-art lectures of Europe's largest GI meeting may be followed online from around the world. Include #UEGWeek in your tweets. UEG Week 24/7 features all recorded sessions from UEG Week and provides convenient and direct access to the complete congress material, including E-posters and abstracts.

About Achalasia and GERD

Achalasia is a disorder that affects the ability of the esophagus to move food into the stomach. Common surgical procedures intended to treat achalasia, such as myotomy, could potentially cause gastroesophageal reflux disease (GERD) as a side effect. 

GERD occurs when the lower esophageal sphincter spontaneously opens or does not properly close after use, thereby allowing for stomach contents to rise into the esophagus, causing heartburn, irritation and potentially other discomforts. It affects approximately 24M Americans each year; 14.5M adults experience GERD symptoms at least twice a week, and 2.4M adults experience severe symptoms. While some patients can attain symptom relief through the use of proton pump inhibiters, or PPIs, (acid reducing medications), there is, however, growing concern around the prolonged chronic use of PPIs, including increased risk of bone fracture, infectious complications, and interference with anti-platelet medication and the adsorption of essential vitamins and minerals. A persistent state of untreatable GERD could potentially lead to Barrett's Esophagus, a precancerous state which can lead to esophageal cancer. Patients who suffer from daily GERD are seven times more likely to develop esophageal cancer.

About MUSE TM

The MUSE TM System is a leading technology in Natural Orifice Transoral Endoscopic Surgery (NOTES) procedures. The single operator system performs anterior partial fundoplication with standard surgical staples in a less invasive way, compared to other surgical procedures. Its intuitive endosurgical platform consists of a single use flexible surgical endostapler, equipped with a proprietary miniature camera, an ultrasonic sight and a range finder. The endostapler, which resembles an endoscope, is designed to be operated by a single user, includes a handle with controls, an 80cm flexible shaft, a 5cm rigid section holding a cartridge with 5 standard 4.8mm titanium surgical staples, a ratchet controlled one-way articulating section, and a distal tip.  The MUSE system is FDA cleared and CE marked.

About Medigus

Medigus is a medical device company specializing in developing minimally invasive endosurgical tools and highly innovative imaging solutions. Medigus is a pioneer developer of a unique proprietary endoscopic device, the MUSE system, to treat gastroesophageal reflux disease (GERD), one of the most common chronic diseases in the western world. As an expert in micro-endoscopic devices, Medigus has developed a range of micro CMOS (complementary metal-oxide semiconductor) and CCD (charge-coupled device) video cameras, including micro ScoutCam TM  1.2, which to the best of the company's knowledge, is the smallest in the world. These innovative cameras are suitable for both medical and industrial applications. The MUSE TM System incorporates Medigus' revolutionary micro ScoutCam TM technology. Based on its proprietary technologies, Medigus designs and manufactures endoscopy and micro camera systems for partner companies, including major players in the medical device and industrial industries. The company is committed to providing integrated solutions to meet all of its customer's imaging needs. Medigus is traded on the TASE (Tel Aviv Stock Exchange). To learn more about the company's advanced technology, please visit http://www.medigus.com/ or www.microscoutcam.com . 

# # #  

MEDIA CONTACT:
Chantal Beaudry/ Carrie Yamond
Lazar Partners Ltd.
212-867-1762
cbeaudry@lazarpartners.com
cyamond@lazarpartners.com

INVESTOR RELATIONS:
Miri Segal-Scharia
Hayden/ MS-IR LLC
917-607-8654
msegal@ms-ir.com

Press release (PDF) http://hugin.info/157792/R/1863951/654081.pdf

HUG#1863951

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sola's 11-Step Push Makes Salon Ownership Less Blind

Updated Category News Views 227

A pristine studio does not pay rent by itself. That is the uncomfortable little truth sitting underneath Sola Salons’ new 11-step roadmap for beauty professionals considering salon-suite ownership. The company is telling stylists, estheticians, nail technicians, massage therapists, and other independent operators to treat the move from commission work to ownership like...

Continue Reading
VeriSilicon's New AI/AR Glasses Tech: Game-Changer?

Updated Category News Views 125

VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...

Continue Reading
FULC, DSGR and OPCH Deals Draw Fresh Shareholder Scrutiny

Updated Category News Views 22

Three proposed transactions have drawn the kind of legal glare that makes shareholders sit up and check the fine print twice. On November 18, 2026, Halper Sadeh LLC said it was investigating deals involving Fulcrum Therapeutics, Distribution Solutions Group, and Option Care Health for possible federal securities-law violations or fiduciary-duty breaches. That is not a...

Continue Reading
MacDill Mold Case Puts Privatized Housing on Notice

Updated Category News Views 58

Four hundred fifty-four people are a hard number to shrug off. The expanded civil case over alleged toxic mold conditions at MacDill Air Force Base now covers 105 military families, up from 39 households when it was filed in September 2025. Their complaint against The Michaels Organization and affiliated entities may be the largest known military-housing lawsuit in the...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 255

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Floating Solar Gets a Serious Test in Central New York

Updated Category News Views 99

A flooded quarry pit outside Cortlandville is getting a second career, and that is more interesting than another solar announcement draped across empty acreage. Third Pillar Power has started construction on Crown City Solar at Suit-Kote Corporation's active Polkville Crushed Stone Facility, pairing a working mine, asphalt plant, and storage terminal with what the...

Continue Reading
Mike Blyth’s Hall of Fame Honors a Builder’s Legacy

Updated Category News Views 147

Recognition earned in the hangar, not a boardroom Aircraft design has a ruthless way of exposing empty talk, which is why Mike Blyth’s November 11 induction into the EAA Homebuilders Hall of Fame carries real weight. The Experimental Aircraft Association’s honor, presented in the Eagle Hangar at the EAA Aviation Museum in Oshkosh, Wisconsin, recognizes a career built...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 32

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 200

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading
CD Rates Offer Stillness as Stocks and Gold Wobble

Updated Category News Views 111

November has delivered the sort of tape that makes a supposedly diversified portfolio feel like a leaky boat. Stocks fell sharply, gold slid to a one-year low after record highs as recently as January, and Treasuries have not provided the dependable ballast many investors expected. When inflation worries and federal-debt concerns shove yields higher, bond prices can drop...

Continue Reading

Top 5 Most Recently Viewed Articles

Surfx Sues ONTOS Over Patent Breach in Plasma Tech

Updated Category News Views 55

Surfx's Legal Gambit: A Staunch Defense of Innovation Surfx Technologies, LLC has taken a bold step by filing a federal lawsuit against ONTOS Equipment Systems, Inc. for allegedly infringing on its patents. It's no walk in the park when your cutting-edge plasma systems are at stake. With busy players in the semiconductor, aerospace, and medical device markets, Surfx isn't...

Continue Reading
GeneDx Faces Securities Fraud Suit Over Fabric Deal

Updated Category News Views 82

Trouble in Paradise: GeneDx's Post-Acquisition Blues Ever get that feeling you’ve been handed a lemon? Well, GeneDx Holdings Corp. (NASDAQ: WGS) seems to be in that very predicament with their acquisition of Fabric Genomics. A deal meant to expand markets now casts a long shadow, and the aftermath is stirring up a securities fraud class action lawsuit. If you dipped...

Continue Reading
Insights on the Growing Aluminum Composite Material Market

Updated Category News Views 191

Understanding the Aluminum Composite Material Market The aluminum composite material (ACM) market is witnessing exciting developments as it is projected to reach USD 10.93 billion by 2034, growing at a CAGR of 6.99%. The demand for aluminum composite materials is increasing due to their lightweight properties, durability, and versatility. These materials are primarily...

Continue Reading
Preeclampsia Diagnostics Market Set for Growth Beyond 2032

Updated Category News Views 158

Overview of Preeclampsia Diagnostics Market The Preeclampsia Diagnostics Market is poised to experience significant growth, driven largely by the increasing prevalence of preeclampsia and enhanced awareness among expectant mothers and healthcare professionals. This growth is fueled by innovative product developments from leading companies within the industry and...

Continue Reading
Inszone Insurance Services Expands with Southerland Acquisition

Updated Category News Views 266

Inszone Insurance Services Expands Its Texas Reach Inszone Insurance Services, a leading provider of commercial, personal, and benefits insurance, is excited to announce its recent acquisition of Southerland and Associates, Inc. This move not only solidifies Inszone's presence in Texas but also enhances its capacity to deliver personalized and diverse insurance solutions...

Continue Reading